Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort.

Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort.

Item
http://www.wikidata.org/entity/Q33728406
Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma: a network meta-analysis: Efficacy of 7 targeted therapies for AHCC.Phase I study of sunitinib and erlotinib in advanced nonsquamous non-small cell lung cancerCurrent status of multimodal & combination therapy for hepatocellular carcinoma.In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours.S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.Safety and feasibility of targeted agent combinations in solid tumours.Treating advanced hepatocellular carcinoma: How to get out of first gear.Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer.Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation.Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.The inverted pyramid of biomarker-driven trials.
P2860

Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort.

Item
http://www.wikidata.org/entity/Q33728406
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase I combination of sorafen ...... tion from an expansion cohort.
@ast
Phase I combination of sorafen ...... tion from an expansion cohort.
@en
type
label
Phase I combination of sorafen ...... tion from an expansion cohort.
@ast
Phase I combination of sorafen ...... tion from an expansion cohort.
@en
prefLabel
Phase I combination of sorafen ...... tion from an expansion cohort.
@ast
Phase I combination of sorafen ...... tion from an expansion cohort.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Phase I combination of sorafen ...... tion from an expansion cohort.
@en
P2093
P2860
P304
P31
P356
10.1158/1535-7163.MCT-09-0868
P433
P478
P50
P577
P698
P932